Effect of levothyroxine therapy in pregnant women with thyroid peroxides antibody on Pregnancy outcomes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201105316152N2

Enrollment

Registered

2011-06-19

Start date

2010-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid peroxides antibody.

Interventions

Intervention 1: Control group: No treatment. Intervention 2: Intervention group: a daily dose of 50 microgram levothyroxine during pregnancy.

Prevention

Control group: No treatment

Intervention group: a daily dose of 50 microgram levothyroxine during pregnancy

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: First trimester pregnancy Exclusion criteria: Thyroid diseases, TSH less than 0.2 or > 4 ng/ml, recurrent abortion (3 consecutive abortions)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Premature delivery. Timepoint: at the end of pregnancy. Method of measurement: observation.	—

Secondary

Measure	Time frame
Premature rupture of membrane. Timepoint: at the end of pregnancy. Method of measurement: observation.;Delivery type. Timepoint: at the end of pregnancy. Method of measurement: observation.;Newborn’s Apgar score. Timepoint: at end of pregnancy. Method of measurement: observation.;Newborn’s weight. Timepoint: at the end of pregnancy. Method of measurement: observation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Seyedoshohadaei

Kurdistan University of Medical Sciences

f.seyedoshohadaei@muk.ac.ir+98 87 1328 2001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026